サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1565773

動物用皮膚科治療薬の世界市場、2024～2031年

Global Veterinary Dermatology Drugs Market 2024-2031

出版日
ページ情報
英文 196 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
動物用皮膚科治療薬の世界市場、2024～2031年
出版日: 2024年09月29日
発行: Orion Market Research
ページ情報: 英文 196 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

動物用皮膚科治療薬市場規模・シェア・動向分析レポート：タイプ別（抗真菌薬、抗菌薬、抗寄生虫薬）、動物種別（伴侶動物、畜産動物）、投与経路別（局所、経口、注射）、流通チャネル別（病院薬局、小売、eコマース）、適応症別（寄生虫感染症、アレルギー性感染症、その他）予測期間（2024-2031年）

動物用皮膚科治療薬市場は予測期間（2024-2031年）にCAGR 9.2％で成長すると予測されます。自己免疫性皮膚疾患、寄生虫性皮膚疾患、ふけ関連皮膚疾患、脱毛症、内在性皮膚感染症など、重篤な疾患が世界中の多くの動物に影響を与えています。このため、動物用皮膚科治療薬の需要が増加しています。市場の成長はまた、世界人口の間でペットの飼育が増加していることにも起因しています。これはコンパニオンアニマルのケアに利用できるサービスや医薬品の急増にプラスに寄与しています。また、ペット動物の皮膚病負担の増加も業界の成長に寄与しています。さらに、市場企業は研究開発に積極的に投資しており、市場の成長を後押ししています。

市場力学

ペット飼育の増加

動物の福祉と健康に対する飼い主の意識の高まりにより、近年、動物用皮膚科治療薬の需要が増加しています。さらに、良好な皮膚の価値を認識する飼い主が増加しており、獣医学の進歩により動物の皮膚病治療の成功率が高まっています。気候変動や公害などの問題により、このような状況は悪化しており、より充実した皮膚専門サービスを含む獣医療への幅広いアクセスを提供する必要があります。オンラインコミュニティやソーシャルメディアプラットフォームも、ペットの飼い主間の情報や経験の流れに貢献し、それによってこのパターンが解明されています。

ペットの皮膚疾患の増加

感染症、環境の変化、寄生虫など、さまざまな要因が複雑に絡み合って、ペットや家畜を含む家畜が罹患する皮膚病の症例が増加しています。寄生虫、例えばノミや食品に含まれるアレルゲンは、動物に皮膚炎などの炎症を起こさせる可能性があります。

市場セグメンテーション

動物用皮膚科治療薬の世界市場を詳細に分析すると、タイプ、動物種、投与経路、流通チャネル、適応症の各セグメントに分けられます。

  • タイプ別に基づき、市場は抗真菌薬、抗菌薬、抗寄生虫薬に区分されます。
  • 動物種に基づき、市場はコンパニオンアニマルと畜産動物に二分されます。
  • 投与経路に基づき、市場は外用剤、経口剤、注射剤に区分されます。
  • 流通チャネルに基づき、病院薬局、小売、eコマースに区分されます。
  • 適応症に基づき、寄生虫感染症、アレルギー性感染症、その他に区分されます。

コンパニオンアニマルが最大セグメントと予測

ペットの飼育数が増加した結果、高品質のペット用製品とサービスに対するニーズが高まっています。この高まりは、獣医学の進歩やこの問題に関する情報普及により、ペットの要求事項に対する理解が深まったことに後押しされています。飼い主は、高級ペットフード、玩具、その他動物の健康関連商品を好むようになっています。

市場セグメンテーションでは、外用薬が大きなシェアを占める。

外用薬は特異性が高く、血流に注射することなく患部に直接簡単に塗布できるため、全身反応や他の薬物成分による変化を最小限に抑えることができます。経口錠剤や懸濁液に比べて投与が簡単なため、獣医師は外用薬を好みます。外用薬は患部に使用することで、より迅速な緩和をもたらし、いくつかの皮膚疾患の治療に有用です。効果的な治療法の選択肢を求める消費者のニーズが高まるにつれ、有効性、安全性、使いやすさに重点を置いた動物用ヘルスケアソリューションの革新という点で、外用薬セグメントは先導的な役割を担っています。

地域別展望

世界の動物用皮膚科治療薬市場は、北米（米国、カナダ）、欧州（英国、イタリア、スペイン、ドイツ、フランス、その他欧州地域）、アジア太平洋（インド、中国、日本、韓国、その他アジア太平洋地域）、世界のその他の地域（中東とアフリカ、中南米）を含む地域別にさらに細分化されています。

北米が主要市場シェアを占める

北米では、皮膚科のような特定の医療を重視する飼い主が多いです。その結果、特定の需要に応える化学治療薬が非常に増えています。そのため、製薬企業はさまざまな動物の皮膚病と闘うための新薬を設計する研究活動に取り組んでいます。

目次

第1章 レポート概要

  • 業界の現状分析と成長ポテンシャルの展望
  • 調査方法とツール
  • 市場内訳
    • セグメント別
    • 地域別

第2章 市場概要と洞察

  • 調査範囲
  • アナリストの洞察と現在の市場動向
    • 主な調査結果
    • 推奨事項
    • 結論

第3章 競合情勢

  • 主要企業分析
  • Ceva Animal Health, LLC
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • Elanco Animal Health Inc.
    • 会社概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • Merck & Co., Inc.
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • Zoetis Services LLC.
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • 主要戦略分析

第4章 市場セグメンテーション

  • 動物用皮膚科治療薬の世界市場：タイプ別
    • 抗真菌薬
    • 抗菌薬
    • 抗寄生虫薬
  • 動物用皮膚科治療薬の世界市場：動物種別
    • 伴侶動物
    • 畜産動物
  • 動物用皮膚科治療薬の世界市場：投与経路別
    • 局所
    • 経口剤
    • 注射剤
  • 動物用皮膚科治療薬の世界市場：流通チャネル別
    • 病院薬局
    • 小売
    • eコマース
  • 動物用皮膚科治療薬の世界市場：適応症別
    • 寄生虫感染症
    • アレルギー性感染症
    • その他（皮膚がん）

第5章 地域別分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • フランス
    • その他欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • 世界のその他の地域
    • ラテンアメリカ
    • 中東・アフリカ

第6章 企業プロファイル

  • AB Science
  • Bayer AG
  • Bimeda Holdings Ltd.
  • Bioiberica S.A.U.
  • Boehringer Ingelheim International GmbH
  • IDEXX Laboratories Inc.
  • Indian Immunologicals Ltd.
  • Leti Pharma, S.L.U.
  • Mars, Inc.
  • Novartis AG
  • SAVAVET
  • Toray Industries, Inc.
  • Vetoquinol Group
  • Virbac Corp.
  • Vivaldis Health & Foods Pvt. Ltd.
図表

LIST OF TABLES

  • 1. Global Veterinary Dermatology Drugs Market Research And Analysis By Type, 2023-2031 ($ Million)
  • 2. Global Antifungal Veterinary Dermatology Drugs Market Research And Analysis By Region, 2023-2031 ($ Million)
  • 3. Global Antibacterial Veterinary Dermatology Drugs Market Research And Analysis By Region, 2023-2031 ($ Million)
  • 4. Global Antiparasitic Veterinary Dermatology Drugs Market Research And Analysis By Region, 2023-2031 ($ Million)
  • 5. Global Veterinary Dermatology Drugs Market Research And Analysis By Animal Type, 2023-2031 ($ Million)
  • 6. Global Veterinary Dermatology Drugs For Companion Animals Market Research And Analysis By Region, 2023-2031 ($ Million)
  • 7. Global Veterinary Dermatology Drugs For Livestock Animals Market Research And Analysis By Region, 2023-2031 ($ Million)
  • 8. Global Veterinary Dermatology Drugs Market Research And Analysis By Route Of Administration, 2023-2031 ($ Million)
  • 9. Global Topical Veterinary Dermatology Drugs Market Research And Analysis By Region, 2023-2031 ($ Million)
  • 10. Global Oral Veterinary Dermatology Drugs Market Research And Analysis By Region, 2023-2031 ($ Million)
  • 11. Global Injectable Veterinary Dermatology Drugs Market Research And Analysis By Region, 2023-2031 ($ Million)
  • 12. Global Veterinary Dermatology Drugs Market Research And Analysis By Distribution Channel, 2023-2031 ($ Million)
  • 13. Global Veterinary Dermatology Drugs In Hospital Pharmacies Market Research And Analysis By Region, 2023-2031 ($ Million)
  • 14. Global Veterinary Dermatology Drugs In Retail Market Research And Analysis By Region, 2023-2031 ($ Million)
  • 15. Global Veterinary Dermatology Drugs In E-Commerce Market Research And Analysis By Region, 2023-2031 ($ Million)
  • 16. Global Veterinary Dermatology Drugs Market Research And Analysis By Indication, 2023-2031 ($ Million)
  • 17. Global Veterinary Dermatology Drugs For Parasitic Infections Market Research And Analysis By Region, 2023-2031 ($ Million)
  • 18. Global Veterinary Dermatology Drugs For Allergic Infections Market Research And Analysis By Region, 2023-2031 ($ Million)
  • 19. Global Veterinary Dermatology Drugs For Others Market Research And Analysis By Region, 2023-2031 ($ Million)
  • 20. Global Veterinary Dermatology Drugs Market Research And Analysis By Region, 2023-2031 ($ Million)
  • 21. North American Veterinary Dermatology Drugs Market Research And Analysis By Country, 2023-2031 ($ Million)
  • 22. North American Veterinary Dermatology Drugs Market Research And Analysis By Type, 2023-2031 ($ Million)
  • 23. North American Veterinary Dermatology Drugs Market Research And Analysis By Animal Type, 2023-2031 ($ Million)
  • 24. North American Veterinary Dermatology Drugs Market Research And Analysis By Route Of Administration, 2023-2031 ($ Million)
  • 25. North American Veterinary Dermatology Drugs Market Research And Analysis By Distribution Channel, 2023-2031 ($ Million)
  • 26. North American Veterinary Dermatology Drugs Market Research And Analysis By Indication, 2023-2031 ($ Million)
  • 27. European Veterinary Dermatology Drugs Market Research And Analysis By Country, 2023-2031 ($ Million)
  • 28. European Veterinary Dermatology Drugs Market Research And Analysis By Type, 2023-2031 ($ Million)
  • 29. European Veterinary Dermatology Drugs Market Research And Analysis By Animal Type, 2023-2031 ($ Million)
  • 30. European Veterinary Dermatology Drugs Market Research And Analysis By Route Of Administration, 2023-2031 ($ Million)
  • 31. European Veterinary Dermatology Drugs Market Research And Analysis By Distribution Channel, 2023-2031 ($ Million)
  • 32. European Veterinary Dermatology Drugs Market Research And Analysis By Indication, 2023-2031 ($ Million)
  • 33. Asia-Pacific Veterinary Dermatology Drugs Market Research And Analysis By Country, 2023-2031 ($ Million)
  • 34. Asia-Pacific Veterinary Dermatology Drugs Market Research And Analysis By Type, 2023-2031 ($ Million)
  • 35. Asia-Pacific Veterinary Dermatology Drugs Market Research And Analysis By Animal Type, 2023-2031 ($ Million)
  • 36. Asia-Pacific Veterinary Dermatology Drugs Market Research And Analysis By Route Of Administration, 2023-2031 ($ Million)
  • 37. Asia-Pacific Veterinary Dermatology Drugs Market Research And Analysis By Distribution Channel, 2023-2031 ($ Million)
  • 38. Asia-Pacific Veterinary Dermatology Drugs Market Research And Analysis By Indication, 2023-2031 ($ Million)
  • 39. Rest Of The World Veterinary Dermatology Drugs Market Research And Analysis By Region, 2023-2031 ($ Million)
  • 40. Rest Of The World Veterinary Dermatology Drugs Market Research And Analysis By Type, 2023-2031 ($ Million)
  • 41. Rest Of The World Veterinary Dermatology Drugs Market Research And Analysis By Animal Type, 2023-2031 ($ Million)
  • 42. Rest Of The World Veterinary Dermatology Drugs Market Research And Analysis By Route Of Administration, 2023-2031 ($ Million)
  • 43. Rest Of The World Veterinary Dermatology Drugs Market Research And Analysis By Distribution Channel, 2023-2031 ($ Million)
  • 44. Rest Of The World Veterinary Dermatology Drugs Market Research And Analysis By Indication, 2023-2031 ($ Million)

LIST OF FIGURES

  • 1. Global Veterinary Dermatology Drugs Market Share By Type, 2023 Vs 2031 (%)
  • 2. Global Antifungal Veterinary Dermatology Drugs Market Share By Region, 2023 Vs 2031 (%)
  • 3. Global Antibacterial Veterinary Dermatology Drugs Market Share By Region, 2023 Vs 2031 (%)
  • 4. Global Antiparasitic Veterinary Dermatology Drugs Market Share By Region, 2023 Vs 2031 (%)
  • 5. Global Veterinary Dermatology Drugs Market Share By Animal Type, 2023 Vs 2031 (%)
  • 6. Global Veterinary Dermatology Drugs For Companion Animals Market Share By Region, 2023 Vs 2031 (%)
  • 7. Global Veterinary Dermatology Drugs For Livestock Animals Market Share By Region, 2023 Vs 2031 (%)
  • 8. Global Veterinary Dermatology Drugs Market Share By Route Of Administration, 2023 Vs 2031 (%)
  • 9. Global Topical Veterinary Dermatology Drugs Market Share By Region, 2023 Vs 2031 (%)
  • 10. Global Oral Veterinary Dermatology Drugs Market Share By Region, 2023 Vs 2031 (%)
  • 11. Global Injectable Veterinary Dermatology Drugs Market Share By Region, 2023 Vs 2031 (%)
  • 12. Global Veterinary Dermatology Drugs Market Share By Distribution Channel, 2023 Vs 2031 (%)
  • 13. Global Veterinary Dermatology Drugs In Hospital Pharmacies Market Share By Region, 2023 Vs 2031 (%)
  • 14. Global Veterinary Dermatology Drugs In Retail Market Share By Region, 2023 Vs 2031 (%)
  • 15. Global Veterinary Dermatology Drugs In E-Commerce Market Share By Region, 2023 Vs 2031 (%)
  • 16. Global Veterinary Dermatology Drugs Market Share By Indication, 2023 Vs 2031 (%)
  • 17. Global Veterinary Dermatology Drugs For Parasitic Infections Market Share By Region, 2023 Vs 2031 (%)
  • 18. Global Veterinary Dermatology Drugs For Allergic Infections Market Share By Region, 2023 Vs 2031 (%)
  • 19. Global Veterinary Dermatology Drugs For Others Market Share By Region, 2023 Vs 2031 (%)
  • 20. Global Veterinary Dermatology Drugs Market Share By Region, 2023 Vs 2031 (%)
  • 21. US Veterinary Dermatology Drugs Market Size, 2023-2031 ($ Million)
  • 22. Canada Veterinary Dermatology Drugs Market Size, 2023-2031 ($ Million)
  • 23. UK Veterinary Dermatology Drugs Market Size, 2023-2031 ($ Million)
  • 24. France Veterinary Dermatology Drugs Market Size, 2023-2031 ($ Million)
  • 25. Germany Veterinary Dermatology Drugs Market Size, 2023-2031 ($ Million)
  • 26. Italy Veterinary Dermatology Drugs Market Size, 2023-2031 ($ Million)
  • 27. Spain Veterinary Dermatology Drugs Market Size, 2023-2031 ($ Million)
  • 28. Rest Of Europe Veterinary Dermatology Drugs Market Size, 2023-2031 ($ Million)
  • 29. India Veterinary Dermatology Drugs Market Size, 2023-2031 ($ Million)
  • 30. China Veterinary Dermatology Drugs Market Size, 2023-2031 ($ Million)
  • 31. Japan Veterinary Dermatology Drugs Market Size, 2023-2031 ($ Million)
  • 32. South Korea Veterinary Dermatology Drugs Market Size, 2023-2031 ($ Million)
  • 33. Rest Of Asia-Pacific Veterinary Dermatology Drugs Market Size, 2023-2031 ($ Million)
  • 34. Latin America Veterinary Dermatology Drugs Market Size, 2023-2031 ($ Million)
  • 35. Middle East And Africa Veterinary Dermatology Drugs Market Size, 2023-2031 ($ Million)
目次
Product Code: OMR2028689

Veterinary Dermatology Drugs Market Size, Share & Trends Analysis Report by Type (Antifungal Drugs, Antibacterial Drugs, and Antiparasitic Drugs), by Animal Type (Companion Animals and Livestock Animals), by Route of Administration (Topical, Oral, and Injectable), Distribution Channel (Hospital Pharmacies, Retail, and E-commerce), and by Indication (Parasitic Infections, Allergic Infections, and Others) Forecast Period (2024-2031)

Veterinary dermatology drugs market is anticipated to grow at a CAGR of 9.2% during the forecast period (2024-2031). Severe diseases affect a lot of animals worldwide, such as autoimmune skin diseases, parasite skin diseases, dander-related skin disorders, alopecia, and intrinsic skin infections. This is leading to an increased demand for veterinary dermatology drugs. The market growth is also attributed to the rising adoption of pets among the global population. This has positively contributed to the surge in the services and medicines available for companion animal care. The increasing burden of dermatological diseases in pet animals is also contributing to the industry's growth. Furthermore, the market players are actively investing in R&D fueling the market growth.

Market Dynamics

Increasing Pet Ownership

There has been an increase in demand for veterinary dermatology drugs in recent times owing to the growing consciousness of pet owners about the welfare and health of their animals. Moreover, an increasing number of pet owners are recognizing the worth of good skin, and there are greater success levels in treating skin diseases in animals because of advances in veterinary medicine. This is worsened by issues such as climate change and pollution, making it necessary to provide broader access to veterinary treatment that includes enhanced skin special services. Online communities and social media platforms have also contributed to the flow of information and experiences between pet owners, thereby elucidating the pattern.

Rising Skin Diseases in Pets

There are complex connections among various factors such as infections, environmental changes, and parasites that have led to the increase in cases of skin diseases affecting domestic animals including pets and livestock. Parasites, for instance, fleas as well as allergens found in food can make animals develop inflammations such as dermatitis.

Market Segmentation

Our in-depth analysis of the global veterinary dermatology drugs market includes the following segments type, animal type, route of administration, distribution channel, and indication.

  • Based on type, the market is segmented into antifungal drugs, antibacterial drugs, and antiparasitic drugs.
  • Based on animal type, the market is bifurcated into companion animals and livestock animals.
  • Based on the route of administration, the market is segmented into topical, oral, and injectable.
  • Based on distribution channels, the market is segmented into hospital pharmacies, retail, and e-commerce.
  • Based on indication, the market is segmented into parasitic infections, allergic infections, and others.

Companion Animal is projected to Emerge as the Largest Segment

The rise in pet ownership has consequently led to an increased need for high-quality pet products and services. This rise has been fueled by an increased understanding of pet requirements due to advancements in veterinary medicine as well as information dissemination on the subject matter. Owners are rendering high preference for high-end pet foods, toys, and other health-related items for animals.

Topical segment to hold a Considerable Market Share

Topical medicines provide high specificity and can be easily applied directly at the affected site without having to be injected into bloodstreams thereby minimizing general body reactions or alterations from other drug elements. Veterinaries prefer topical drugs as they are easier to administer in comparison to oral tablets and suspensions. They deliver faster relief when used on the affected spot and are useful for treating several skin conditions. As consumer need for effective therapy choices rises, the topical segment is leading the way in terms of animal health care solutions innovation focusing on efficacy, safety, as well as ease of use.

Regional Outlook

The global veterinary dermatology drugs market is further segmented based on geography including North America (the US, and Canada), Europe (the UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa, and Latin America).

North America Holds Major Market Share

A larger number of pet owners in North America emphasize specific types of medical care such as dermatological procedures. Consequently, the rise in chemical cures that meet specific demands has been very high. Thus, pharmaceutical enterprises have been involved in research activities to design new drugs to fight against various animal skin illnesses.

Market Players Outlook

The major companies serving the global veterinary dermatology drugs market include Bimeda, Inc., Ceva Sante Animale, Elanco, Merck & Co., Inc., and Zoetis Inc., among others. The market players are increasingly focusing on business expansion and product development by applying strategies such as collaborations, mergers and acquisitions to stay competitive in the market. For instance, in January 2021, Ceva Animal Health, LLC launched a new skincare brand known as Douxo S3 Pyo for cats and dogs. It is intended to offer a simple way of using antibacterial to enhance moisture content & barrier function in their ecosystem.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. Ceva Animal Health, LLC
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. Elanco Animal Health Inc.
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Merck & Co., Inc.
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Zoetis Services LLC.
    • 3.5.1. Overview
    • 3.5.2. Financial Analysis
    • 3.5.3. SWOT Analysis
    • 3.5.4. Recent Developments
  • 3.6. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Veterinary Dermatology Drugs Market by Type
    • 4.1.1. Antifungal Drugs
    • 4.1.2. Antibacterial Drugs
    • 4.1.3. Antiparasitic Drugs
  • 4.2. Global Veterinary Dermatology Drugs Market by Animal Type
    • 4.2.1. Companion Animals
    • 4.2.2. Livestock Animals
  • 4.3. Global Veterinary Dermatology Drugs Market by Route of Administration
    • 4.3.1. Topical
    • 4.3.2. Oral
    • 4.3.3. Injectable
  • 4.4. Global Veterinary Dermatology Drugs Market by Distribution Channel
    • 4.4.1. Hospital Pharmacies
    • 4.4.2. Retail
    • 4.4.3. E-commerce
  • 4.5. Global Veterinary Dermatology Drugs Market by Indication
    • 4.5.1. Parasitic Infections
    • 4.5.2. Allergic Infections
    • 4.5.3. Others (Skin Cancer)

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World
    • 5.4.1. Latin America
    • 5.4.2. Middle East & Africa

6. Company Profiles

  • 6.1. AB Science
  • 6.2. Bayer AG
  • 6.3. Bimeda Holdings Ltd.
  • 6.4. Bioiberica S.A.U.
  • 6.5. Boehringer Ingelheim International GmbH
  • 6.6. IDEXX Laboratories Inc.
  • 6.7. Indian Immunologicals Ltd.
  • 6.8. Leti Pharma, S.L.U.
  • 6.9. Mars, Inc.
  • 6.10. Novartis AG
  • 6.11. SAVAVET
  • 6.12. Toray Industries, Inc.
  • 6.13. Vetoquinol Group
  • 6.14. Virbac Corp.
  • 6.15. Vivaldis Health & Foods Pvt. Ltd.